NanoPass is revolutionizing intradermal injection therapy through the innovative MicronJet(TM) platform, for medical (vaccines/pandemics, drugs, anesthesia, children's care, etc.) and aesthetic applications. Enhanced clinical outcomes, more precise, dose reduction, safer, virtually pain-free, and cost-effective. Harnessing cutting-edge silicon crystal empowered by MEMS technology. Backed by over 70 clinical studies. Fully regulated and sold globally.